President's Message

Dear Colleagues:

As summer ends, let us share with some very good news about the Annual Meeting that we would like to bring to your attention.


First and foremost, there are several developments and exciting sessions that will be included in the program during our time in Charlotte. One being the Robert A. Good Lecturer will be Harvey J. Alter, MD, 2020 Nobel Prize in Physiology or Medicine for his contributions to the discovery of the hepatitis C virus. Dr. Alter will be speaking on, “Hepatitis C: The End of the Beginning and Possibly the Beginning of the End”. We are thrilled to have Dr. Alter join us in Charlotte.


Additionally, the Fahey/Rose Lecturer has been named as Dr. John N, Nkengasong, MSc, PhD. Dr. Nkengasong is currently serving as the Director of the Africa Centres for Disease Control and Prevention. We are thrilled that Dr. Nkengasong will be joining us for the Annual Meeting.


The Diversity & Inclusion Committee in partnership with the Women in Clinical Immunology Sciences (WCIS) Committee are currently planning for their session, which will take place at the Annual Meeting. While details of a speaker are still being worked out, the Committee will soon be conducting a diversity survey, the results of which will be presented during their session during the Annual Meeting. Please keep an eye on your inbox, as this data is extremely important for us to capture.


We are also preparing many more exciting clinical and translational clinical immunology sessions to be presented by our own CIS members. Plan on joiningus at the Annual Meeting as you cannot (and should not) miss this learning, collaboration and networking opportunity.


In addition, Abstract Submission is now open and keep an eye on your inbox as registration for the meeting will be opening soon! We took a year off from meeting in person, but on behalf of the Annual Meeting Scientific Program Committee and the CIS Executive Committee we will be so excited to see everyone in person in Charlotte in April. 



Sergio Rosenzweig, MD, PhD
CIS President 2021-2023